TAKEAWAYSDefine 2 reporting levels for each ingredient: specify zinc-salt addition versus elemental zinc, and extract addition versus named catechin content. Ask the OEM to state the material assay and calculation basis.Use 4 development comparisons to investigate the blend: compare the base, zinc-o Read More

TAKEAWAYSThree launch routes create different first-order commitments: stock, modified stock and fully custom projects each require a different quotation basis. “Private label” does not automatically mean a custom formula or fixed MOQ.Four component choices often move the commercial floor: bottle av Read More

TAKEAWAYSTwo identity documents are better than one “natural sweetener” note: request a steviol-glycoside profile for stevia or a mogroside-V basis for monk fruit, with the assay method and carrier declaration. A trade name alone cannot predict taste.Three sensory timepoints expose a weak formula: s Read More

TAKEAWAYSApprove 3 distinct evidence tracks: appliance cleaning, named-material compatibility, and the oral/brushing route.Name the material panel: do not infer broad compatibility from one tray or one study.Test the final formula and pack at 4 states: prime, repeated use, post-storage, and near-emp Read More

TAKEAWAYSOne declared lysozyme amount is not one activity result: a raw-material COA identifies the incoming enzyme; an activity method on the finished matrix shows whether the agreed function is still measurable after formulation and processing.A final formula needs its own matrix screen: pH, buffe Read More

TAKEAWAYS2 surface-stain endpoints must stay separate: removing existing extrinsic stain and helping limit new stain accumulation need different study designs, claims, and success criteria.3 fluoride values may need review: the added amount, total fluoride, and the pre-defined free or available fluo Read More

TAKEAWAYS3 formats should have 3 different jobs: a spray can support a portable application moment, a gel can be assessed for a more retained-feel application, and a rinse can fit a measured routine; they are not interchangeable treatment claims.1 small case series is not a product claim dossier: cu Read More

TAKEAWAYSK12 and M18 are named strain routes, not two labels for the same active: request the complete strain designation, identity method, authorized source, and evidence file before artwork or quotation.A probiotic lozenge and a probiotic chewable are different delivery briefs: dissolution time, s Read More

TAKEAWAYSCoffee/wine “stain prevention” needs final-product support: coffee and red wine are relevant laboratory challenges, but that does not prove a particular spray prevents stain formation in real use.[1]Choose one product job first: sensory refresh, measured external-stain care, and broader whi Read More

TAKEAWAYS1. Treat five inputs as separately specified candidates: papain, lysozyme, sodium pyrophosphate, sodium tripolyphosphate, and sodium phytate need their own identity, grade, supplier lot, formula basis, and compatibility review.2. Use four matched samples rather than one “enhanced” prototype Read More

TAKEAWAYSAn xylitol claim needs 3 records—not 1 percentage: Approve the material/formula basis, formula addition and final pump-delivered amount separately. A percentage alone cannot describe what the finished foam system delivers.Taste and foam must be screened as 1 system: Compare 3 xylitol direct Read More

TAKEAWAYSThree numbers must stay separate: supplier assay, formula addition level and finished-product level are not interchangeable. Put all 3 in the sample brief before comparing suppliers.0.1% is a research condition, not a spray recommendation: a 2025 canine study used 0.1% purified persimmon-ta Read More